跳至主要内容
临床试验/NCT00726362
NCT00726362已完成不适用

To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

AstraZeneca1 个研究点 分布在 1 个国家目标入组 3,270 人开始时间: 2007年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
3,270
试验地点
1
主要终点
Changes on LDL-C, HDL-C, TG, TC

研究概览

简要总结

The primary objective is to survey the efficacy of various commercially available statins (a class of lipid-lowering agents, for example, rosuvastatin, atorvastatin, simvastatin, lovastatin, pravastatin and fluvastatin) under local clinical practice in treating patients with hyperlipidemia. Surveillance data (Lipid Profile) will be collected during course of usual clinical practice or captured upon its availability.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients diagnosed with hyperlipidemia
  • •Patients who are just starting a statin treatment, who need to switch from current therapy to a statin medication, or who are receiving dosage adjustment of statin as judged by the physicians
  • •Patients who are willing to participate in this study and who sign an informed consent form

排除标准

  • •Pregnancy or breast feeding
  • •Patient are illiterate or unable to fill the questionnaire for any reason
  • •Patients with contraindications to the use of certain statins as needed prescribed by physicians (as per commercially available statins package insert) including the use of rosuvastatin.
  • •Any clinical condition which, in the opinion of the attending physician, would not allow safe administration of the study medications

结局指标

主要结局

Changes on LDL-C, HDL-C, TG, TC

时间窗: 3~6 months

次要结局

  • ratio for treatment-to-goal(3~6 months)
  • drug compliance(3~6 months)
  • correlation between patient's insight and therapeutic outcome(3~6 months)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

To Explore the Treatment Effect of Various... | 临床试验